Evaluation of QTc interval prolongation in patients with advanced clear cell renal cell carcinoma treated with first line sunitinib.
| Published in: | Cancer Chemotherapy & Pharmacology Vol. 96; no. 1; pp. 1 - 12 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Journal Article |
| Published: |
Springer Nature
9/17/2026
|
| Online Access: | View this record in EBSCOhost |
| Description not available. |